+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors



Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors



Modern Pathology 11(8): 774-779



We compared the expression of inhibin A, chromogranin, synaptophysin, S-100 protein, cytokeratins AE1/AE3, 7, and 20, and estrogen and progesterone receptors in testicular sex cord-stromal tumors: 11 Sertoli cell tumors, 3 Sertoli cell adenomas (nodules), 26 benign Leydig cell tumors, 7 malignant Leydig cell tumors (defined clinically by metastatic behavior), and a variety of germ cell tumors. Inhibin was the most sensitive marker, expressed in 91% of the Sertoli cell tumors and 100% of the Sertoli cell adenomas and Leydig cell tumors. The non-neoplastic Sertoli and Leydig cells invariably stained for inhibin. Conversely, no germ cell tumors were immunoreactive. One testicular tumor of the adrenogenital syndrome was immunoreactive. Neuroendocrine marker immunoreactivity was variable. Chromogranin was expressed in the non-neoplastic Sertoli and Leydig cells, 82% of the Sertoli cell tumors, 92% of the benign Leydig cell tumors, and 43% of the malignant Leydig cell tumors. Synaptophysin was expressed in the non-neoplastic Sertoli and Leydig cells, 45% of the Sertoll cell tumors, and 70% of the Leydig cell tumors, in approximately similar proportions between the benign and malignant Leydig cell tumors. S-100 protein was expressed in 64% of the Sertoli cell tumors, 8% of the benign Leydig cell tumors, and none of the malignant Leydig cell tumors. Cytokeratins AE1/AE3 were expressed in 64% of the Sertoli cell tumors and 42% of the Leydig cell tumors, with similar proportions in the benign and malignant cases. Estrogen and progesterone receptor expression were identified in 24 and 39% of benign and malignant Leydig cell tumors, respectively. We conclude that inhibin is a characteristic marker for Sertoli and Leydig cells and that it serves to differentiate testicular sex cord-stromal tumors from germ cell tumors.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008874826

Download citation: RISBibTeXText

PMID: 9720507


Related references

Calretinin, a More Sensitive but Less Specific Marker Than -Inhibin for Ovarian Sex Cord-Stromal Neoplasms. The American Journal of Surgical Pathology 26(11): 1477-1483, 2002

Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. American Journal of Surgical Pathology 26(11): 1477-1483, 2002

Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal and fibrous neoplasms An immunohistochemical study of 206 cases. Laboratory Investigation 82(1): 203A-204A, 2002

FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. American Journal of Surgical Pathology 35(4): 484-494, 2011

FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary. Yearbook of Pathology and Laboratory Medicine 2012: 117-119, 2012

Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. American Journal of Surgical Pathology 21(5): 583-589, 1997

Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. American Journal of Surgical Pathology 22(5): 615-619, 1998

Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Human Pathology. 29(8): 840-845,., 1998

Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors. American Journal of Obstetrics and Gynecology 177(6): 1450-1457, 1998

Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors. American Journal of Obstetrics & Gynecology 177(6): 1450-1457, 1997

CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. International Journal of Gynecological Pathology 26(3): 322-327, 2007

CD117 A sensitive and specific marker for gastrointestinal stromal tumors. Modern Pathology 12(1): 71A, 1999

Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms. Human Pathology 65: 1-14, 2017

CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modern Pathology 11(8): 728-734, 1998

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. American Journal of Surgical Pathology 32(2): 210-218, 2008